Dr. Xue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
251 E Huron St
Ste 7-332
Chicago, IL 60611Phone+1 312-926-3211Fax+1 312-926-3127
Education & Training
- Harbin Medical UniversityClass of 1994
Certifications & Licensure
- IL State Medical License 2019 - 2026
- GA State Medical License 2014 - 2025
- OH State Medical License 2023 - 2025
- NY State Medical License 2013 - 2015
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis.Aslihan Yavas, Kerem Ozcan, N Volkan Adsay, Serdar Balci, Zeynep C Tarcan
Modern Pathology. 2024-11-01 - Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolvi...Ozgur Can Eren, Pelin Bagci, Serdar Balci, Nobuyuki Ohike, Burcu Saka
Annals of Surgical Oncology. 2024-10-01 - ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.Ozgur Can Eren, Pelin Bagci, Serdar Balci, Nobuyuki Ohike, Burcu Saka
Annals of Surgical Oncology. 2024-10-01
Journal Articles
- T Cell Receptor Sequencing of Activated CD8 T Cells in the Blood Identifies Tumor-Infiltrating Clones That Expand After PD-1 Therapy and Radiation in a Melanoma PatientJonathan J Masor, Juan Sarmiento, Walter J Curran, David H Lawson, Rafi Ahmed, Yue Xue, Cancer Immunology, Immunotherapy
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: